A drug currently used to treat asthma may have a role in preventing age-related cognitive decline, an exploratory study suggests. Treatment with the asthma drug montelukast successfully restored cognitive function and increased the creation of new brain cells in old rats, the results of the study published in Nature Communications showed. These findings provide an early ...
Already a member?
Enter your email to keep reading.